Paediatric models in motion: Requirements for model-based decision support at the bedside

British Journal of Clinical Pharmacology

Volumn 79, Issue 1, 2015, Pages 85-96

  Barrett, Jeffrey S ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

decision support; models; paediatric; personalized medicine

Indexed keywords

ARTICLE; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; CONTINUOUS PROCESS; DECISION SUPPORT SYSTEM; DRUG MONITORING; FOLLOW UP; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; MODEL BASED DECISION SUPPORT; PATIENT CARE; PATIENT SATISFACTION; QUALITY CONTROL; BIOLOGICAL MODEL; CHILD; PEDIATRICS; PERSONALIZED MEDICINE; PROGRAM DEVELOPMENT;

CHILD; DECISION SUPPORT TECHNIQUES; HUMANS; MODELS, BIOLOGICAL; PEDIATRICS; PRECISION MEDICINE; PROGRAM DEVELOPMENT;

EID: 84919629629     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12287     Document Type: Article

References (53)

1. Gobburu JV, Sekar VJ,. Application of modeling and simulation to integrate clinical pharmacology knowledge across a new drug application. Int J Clin Pharmacol Ther 2002; 40: 281-288.
2. Laer S, Barrett JS, Meibohm B,. The in silico child: using simulation to guide pediatric drug development and manage pediatric pharmacotherapy. J Clin Pharmacol 2009; 49: 889-904.
3. CDER. Innovation and Stagnation: Challenge and Opportunity on the Critical Path to New Medicinal Products. US Department of Health and Human Services, Washington, DC: US Food and Drug Administration, 2006.
4. IOM report: patient safety-achieving a new standard for care. Acad Emerg Med 2005; 12: 1011-1012.
5. Boye N, Veirum NE,. Ontology-based, medical domain-specific, use-case driven EMRs for use in clinical quality assurance and passive decision support. Stud Health Technol Inform 2000; 70: 36-38.
6. Teufel RJ, Kazley AS, Ebeling MD, Basco WT, Jr. Hospital electronic medical record use and cost of inpatient pediatric care. Acad Pediatr 2012; 12: 429-435.
7. White DB,. The identification of best practices in teaching quality competencies for preparing future health care leaders. J Health Adm Educ 2005; 22: 321-344.
8. Barretto SA, Warren J, Goodchild A, Bird L, Heard S, Stumptner M,. Linking guidelines to Electronic Health Record design for improved chronic disease management. AMIA Annu Symp Proc, 2003: p. 66-70.
9. Isken MW, Rajagopalan B,. Data mining to support simulation modeling of patient flow in hospitals. J Med Syst 2002; 26: 179-197.
10. Chu A, Ahn H, Halwan B, Kalmin B, Artifon EL, Barkun A, Lagoudakis MG, Kumar A,. A decision support system to facilitate management of patients with acute gastrointestinal bleeding. Artif Intell Med 2008; 42: 247-259.
11. Freedman RA, Hopper DL, Mah J, Hummel J, Wilkoff BL,. Assessment of pacemaker chronotropic response: implementation of the Wilkoff mathematical model. Pacing Clin Electrophysiol 2001; 24: 1748-1754.
12. Hann CE, Chase JG, Shaw GM,. Efficient implementation of non-linear valve law and ventricular interaction dynamics in the minimal cardiac model. Comput Methods Programs Biomed 2005; 80: 65-74.
13. Jornil J, Jensen KG, Larsen F, Linnet K,. Risk assessment of accidental nortriptyline poisoning: the importance of cytochrome P450 for nortriptyline elimination investigated using a population-based pharmacokinetic simulator. Eur J Pharm Sci 2011; 44: 265-272.
14. Picchini U, De Gaetano A, Panunzi S, Ditlevsen S, Mingrone G,. A mathematical model of the euglycemic hyperinsulinemic clamp. Theor Biol Med Model 2005; 2: 44.
15. Rees SE, Allerod C, Murley D, Zhao Y, Smith BW, Kjaergaard S, Thorgaard P, Andreassen S,. Using physiological models and decision theory for selecting appropriate ventilator settings. J Clin Monit Comput 2006; 20: 421-429.
16. Schurink CA, Visscher S, Lucas PJ, van Leeuwen HJ, Buskens E, Hoff RG, Hoepelman AI, Bonten, MJ,. A Bayesian decision-support system for diagnosing ventilator-associated pneumonia. Intensive Care Med 2007; 33: 1379-1386.
17. Ay H, Gungor L, Arsava EM, Rosand J, Vangel M, Benner T, Schwamm LH, Furie KL, Koroshetz WJ, Sorensen AG,. A score to predict early risk of recurrence after ischemic stroke. Neurology 2010; 74: 128-135.
18. Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G, Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett L, Voora D, Veenstra DL, Glynn RJ, Barrett A, McLeod HL,. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther 2008; 84: 326-331.
19. Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE,. Natural history of post-liver transplantation hepatitis C: a review of factors that may influence its course. Liver Transpl 2009; 15: 1872-1881.
20. Kim WR, Dickson ER,. Predictive models of natural history in primary biliary cirrhosis. Clin Liver Dis 1998; 2: 313-331.
21. Monchaud C, de Winter BC, Knoop C, Estenne M, Reynaud-Gaubert M, Pison C, Stern M, Kessler R, Guillemain R, Marquet P, Rousseau A,. Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation. Clin Pharmacokinet 2012; 51: 175-186.
22. Olson JC, Kamath PS,. Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr Opin Crit Care 2011; 17: 165-169.
23. Schadow G, Russler DC, Mead CN, McDonald CJ,. Integrating medical information and knowledge in the HL7 RIM. Proc AMIA Symp, 2000: p. 764-768.
24. Trafton JA, Martins SB, Michel MC, Wang D, Tu SW, Clark DJ, Elliott J, Vucic B, Balt S, Clark ME, Sintek CD, Rosenberg J, Daniels D, Goldstein MK,. Designing an automated clinical decision support system to match clinical practice guidelines for opioid therapy for chronic pain. Implement Sci 2010; 5: 26.
25. Barrett JS, Mondick JT, Narayan M, Vijayakumar K, Vijayakumar S,. Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapy. BMC Med Inform Decis Mak 2008; 8: 6.
26. Hirankarn S, Dombrowsky E, Patel D, Barrett JS,. High-dose methotrexate in children with cancer: a population pharmacokinetic study. J Clin Pharmacol 2010; 50: 1072 (Abstr 67).
27. Dombrowsky E, Jayaraman B, Narayan M, Barrett JS,. Evaluating performance of a decision support system to improve methotrexate pharmacotherapy in children and young adults with cancer. Ther Drug Monit 2011; 33: 99-107.
28. Pescovitz MD, Knechtle S, Alexander SR, Colombani P, Nevins T, Nieforth K, Bouw MR,. Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipients. Pediatr Transplant 2008; 12: 447-455.
29. Staatz CE, Taylor PJ, Lynch SV, Willis C, Charles BG, Tett SE,. Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants. Transplantation 2001; 72: 1056-1061.
30. Zhao W, Elie V, Roussey G, Brochard K, Niaudet P, Leroy V, Loirat C, Cochat P, Cloarec S, Andre JL, Garaix F, Bensman A, Fakhoury M, Jacqz-Aigrain, E,. Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients. Clin Pharmacol Ther 2009; 86: 609-618.
31. Cattaneo D, Vinks AA,. Optimizing immunosuppressive drug dosing in pediatric renal transplantation. Part of a special series on Paediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni. Pharmacol Res 2012; 65: 163-167.
32. Pestian J, Spencer M, Matykiewicz P, Zhang K, Vinks AA, Glauser T,. Personalizing drug selection using advanced clinical decision support. Biomed Inform Insights 2009; 2: 19-29.
33. McCune JS, Baker KS, Blough DK, Gamis A, Bemer MJ, Kelton-Rehkopf MC, Winter L, Barrett JS,. Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipients. J Clin Pharmacol 2013; 53: 264-275.
34. Avery PJ, Jorgensen A, Hamberg AK, Wadelius M, Pirmohamed M, Kamali F,. A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy. Clin Pharmacol Ther 2012; 90: 701-706.
35. Biss T, Hamberg AK, Avery P, Wadelius M, Kamali F,. Warfarin dose prediction in children using pharmacogenetics information. Br J Haematol 2012; 159: 106-109.
36. Hamberg AK, Friberg LE, Hanseus K, Ekman-Joelsson BM, Sunnegardh J, Jonzon A, Lundell B, Jonsson EN, Wadelius M,. Warfarin dose prediction in children using pharmacometric bridging-comparison with published pharmacogenetic dosing algorithms. Eur J Clin Pharmacol 2013; 69: 1275-1283.
37. Abdel-Rahman SM, Ahlers N, Holmes A, Wright K, Harris A, Weigel J, Hill T, Baird K, Michaels M, Kearns GL,. Validation of an improved pediatric weight estimation strategy. J Pediatr Pharmacol Ther 2013; 18: 112-121.
38. Jelliffe R,. Goal-oriented, model-based drug regimens: setting individualized goals for each patient. Ther Drug Monit 2000; 22: 325-329.
39. Jelliffe R,. Individual dose optimization: why and how. Int J Clin Pharmacol Ther 2004; 42: 183-184.
40. Jelliffe RW, Maire P, Sattler F, Gomis P, Tahani B,. Adaptive control of drug dosage regimens: basic foundations, relevant issues, and clinical examples. Int J Biomed Comput 1994; 36: 1-23.
41. Neely M, Jelliffe R,. Practical therapeutic drug management in HIV-infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose optimization. J Clin Pharmacol 2008; 48: 1081-1091.
42. Alcorn J, Elbarbry FA, Allouh MZ, McNamara PJ,. Evaluation of the assumptions of an ontogeny model of rat hepatic cytochrome P450 activity. Drug Metab Dispos 2007; 35: 2225-2231.
43. Alcorn J, McNamara PJ,. Using ontogeny information to build predictive models for drug elimination. Drug Discov Today 2008; 13: 507-512.
44. Anderson BJ, Holford NH,. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008; 48: 303-332.
45. Anderson GD, Lynn AM,. Optimizing pediatric dosing: a developmental pharmacologic approach. Pharmacotherapy 2009; 29: 680-690.
46. Holford N,. Dosing in children. Clin Pharmacol Ther 2010; 87: 367-370.
47. Collins SA, Bakken S, Vawdrey DK, Coiera E, Currie L,. Model development for EHR interdisciplinary information exchange of ICU common goals. Int J Med Inform 2011; 80: e141-149.
48. Longhurst C, Turner S, Burgos AE,. Development of a Web-based decision support tool to increase use of neonatal hyperbilirubinemia guidelines. Jt Comm J Qual Patient Saf 2009; 35: 256-262.
49. Regier R, Gurjar R, Rocha RA,. A clinical rule editor in an electronic medical record setting: development, design, and implementation. AMIA Annu Symp Proc, 2009. 2009: 537-541.
50. Vittorini P, Tarquinio A, di Orio F,. XML technologies for the Omaha System: a data model, a Java tool and several case studies supporting home healthcare. Comput Methods Programs Biomed 2009; 93: 297-312.
51. Friedlin J, Dexter PR, Overhage JM,. Details of a successful clinical decision support system. AMIA Annu Symp Proc 2007; 254-258.
52. Martin P, Haefeli WE, Martin-Facklam M,. A drug database model as a central element for computer-supported dose adjustment within a CPOE system. J Am Med Inform Assoc 2004; 11: 427-432.
53. Anoshiravani A, Gaskin G, Kopetsky E, Sandborg C, Longhurst CA,. Implementing an interoperable personal health record in pediatrics: lessons learned at an academic children's hospital. J Particip Med 2011; 3: e30.